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Objective. Adenoid hypertrophy is a common condition in childhood, which may be associated with recurring acute otitis media
(RAOM), otitis media with effusion (OME), and obstructive sleep apnea syndrome (OSAS). These different clinical characteristics
have some clinical overlap; however, they might be explained by distinct immunologic and infectious profiles and result in
various histopathologic findings of adenoid specimens. Methods. A total of 59 children with adenoid hypertrophy undergoing
adenoidectomy were studied. Three series of identical adenoid specimens were processed to hematoxylin-eosin (H.E.) and Gram
staining and to respiratory virus specific real-time PCR, respectively. Results. According to the clinical characteristics, patients were
recruited into three groups: RAOM (𝑛 = 25), OME (𝑛 = 19), and OSAS (𝑛 = 15). Bacterial biofilms were detected in 21 cases, while
at least one of the studied respiratory viruses was detected in 52 specimens. RAOM cases were significantly associated with biofilm
existence (𝑛 = 20, 𝑃 < 0.001). In contrast, OME group was characterized by the absence of bacterial biofilm and by normal mucosa.
Showing a statistically significant correlation, all OME cases were positive for human bocavirus (HBoV, 𝑃 < 0.001). Conclusions.
Bacterial biofilms might contribute to the damage of respiratory epithelium and recurring acute infections resulting in RAOM. In
OMEcases persisting respiratory viruses,mainlyHBoV, can cause subsequent lymphoid hyperplasia leading to ventilation disorders
and impaired immunoreactivity of the middle ear cleft.
1. Introduction
Adenoid hypertrophy (adenoid vegetation) and associated
symptoms of children are a common condition in pediatrics
and ENT practice that is responsible for a great amount of
medical visits and one of the main reasons for antibiotic
treatment and parental leave of work [1]. Nasopharyngeal
obstruction caused by adenoid hypertrophy may lead to sev-
eral other diseases and symptoms such as hyponasality, snor-
ing, obstructive sleep apnea syndrome (OSAS), acute otitis
media, otitis media with effusion (OME), middle ear atelec-
tasia, cholesteatoma formation, slow feeding, acute sinusitis,
abnormal facial development, and behavioral problems [2–
5]. Adenoidectomy with or without tympanocentesis or
ventilation tube insertion is a useful surgical intervention to
treat hearing problems, obstructive sleep apnea syndrome,
and to prevent recurring otitis media, recurring sinusitis, and
cholesteatoma formation or middle ear atelectasia [6–8]. In
Hungary (population is 10million), 6–9,000 adenoidectomies
have been performed annually in the latest years emphasizing
the extent of this condition. The annual number of reported
adenoidectomies varies between 15,000 and 50,000 in the
United States and between 50,000 and 70,000 in the European
Union [7, 8]. In the clinical practice, symptoms and condi-
tions associated with adenoid hypertrophy can be classified
into distinct clinical groups as follows: (1) recurring acute
otitis media (RAOM), (2) otitis media with effusion (OME),
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and (3) obstructive sleep apnea syndrome (OSAS) [9–13].
In contrast to potential clinical overlaps, clinical behavior,
recurrence rates, and therapeutic responses are absolutely
different in these groups [1, 11, 12, 14]. Hypertrophic adenoid
(epipharyngeal tonsil) may directly obstruct the ostia of
Eustachian tubes predisposing children to OME [1, 2, 10].
However, this mechanical hypothesis is not widely accepted
[15, 16]. Recurring and chronic infections of the adenoids
without manifesting nasopharyngeal obstruction may also
lead to the aforementioned conditions by tubal edema and
functional disorders supporting the reservoir theory [1, 9, 17].
Diagnosis of adenoid hypertrophy associated with OME
is based on the duration of conductive hearing disorder, type-
B tympanograms, and positive otoscopic findings, which
persists over 12weeks despitemedical treatment [10, 11]. OME
is a separate diagnostic entity, although the etiopathogenesis
is still unclarified [3, 9, 15, 16]. Several hypotheses have
been arisen in the explanation of the pathogenesis of OME,
which is currently thought to be an immunologic disease
affected by multiple factors [10, 15, 16]. These are persist-
ing respiratory viral infections, immunological dyscrasias,
alimentary allergies, allergic rhinitis, bronchial asthma, and
Eustachian tube functional disorders [3, 14, 15, 18]. There is
increasing evidence that persisting respiratory viruses and
impaired immunoreactions may play a promoting role in the
pathogenesis of OME associated with adenoid hypertrophy
[18–20].
OSAS in childhood is a complex clinical condition that
can be affected by several anatomic and pathologic disor-
ders, as well as adenoid hypertrophy, tonsillar hypertrophy,
nasal obstruction, laryngeal malformations, macroglossia,
maxillofacial malformations, and so forth [12, 13]. As to our
current knowledge, pure OSAS cases associated to simple
adenoid hypertrophy have not been attributed to immuno-
logic or infectious disorders [12, 13].
RAOM is also a separate clinical entity, which might be
associated to the presence of bacterial biofilms on the surface
of epipharyngeal mucosa [17, 21, 22]. Biofilm creates a special
environment for microbial survival and proliferation that
consists of a self-produced, three-dimensional extracellular
matrix formed by polysaccharides, proteins, nucleic acids,
and water [21, 23, 24]. Microbial biofilms are characterized
by extremely high resistance against antibiotics, host immune
reactions, and chemical and physical agents [21, 22]. This
strong and continuously remodeled physical barrier blocks
the diffusion of antibiotics, superoxides, immunoglobulins,
and opsonins [21, 25]. Biofilms and consecutive inflammatory
reactions might contribute to the epithelial damage and
subsequent hyperplasia of the subepithelial layer resulting
in adenoid hypertrophy [1, 9, 23, 24]. It has been reported
that persisting biofilms in adenoid hypertrophy may be
responsible for surgical failures and high recurrence rate of
acute suppurative otitis media [3, 8, 10, 15].
This study investigates the presence of bacterial biofilms
and respiratory viruses in adenoid specimens obtained from
patientswith adenoid hypertrophy and associated conditions.
Histopathologic findings and respiratory virus specific real-
time PCR results were correlated to the clinical characteristics
of prospectively formed patient groups.
2. Materials and Methods
2.1. Patients. A prospective case-control experimental study
was performedon adenoid specimens obtained fromchildren
with adenoid hypertrophy who underwent adenoidectomy at
the Department of Otorhinolaryngology and Head and Neck
Surgery, University of Debrecen. Adenoid samples (𝑛 = 59)
were collected between January and May 2012. The patient
group consisted of 37 males and 22 females (𝑛 = 59, mean
age = 5.09 years; range = 3–11 years) with the diagnosis
of adenoid hypertrophy and associated symptoms such as
otitis media with effusion, recurring acute otitis media, and
obstructive sleep apnea syndrome. Clinical diagnosis was
confirmed by preoperative evaluation of patients’ history
obtaining heteroanamnesis from parents and by physical
and audiologic examinations. During the prospective data
collection, patients were recruited into three clinical cate-
gories forming distinct groups of (1) recurring acute otitis
media (RAOM), (2) otitis media with effusion (OME), and
(3) obstructive sleep apnea syndrome (OSAS), respectively.
Inclusion criteria were based on the rate of episodes of acute
suppurative otitis media, acute sinusitis or sinobronchitis, on
the otoscopic findings, audiologic examinations (pure tone
threshold audiometry and tympanometry), and finally on
patients’ history. All surgical interventions were performed
under intratracheal narcosis. All the adenoid samples col-
lected during adenoidectomy were divided into two con-
secutive groups consisting of 59 specimens each that were
processed to histopathologic analysis and respiratory virus
specific real-time PCR, respectively. All adenoid specimens
were larger than 2 centimeters of diameter, which could be
removed by a sharp adenotom device without any surface
injury or iatrogenic disruption of biofilm layers.The transoral
removal was gently performed at the basis of adenoids avoid-
ing the surgical injury of torus tubarius, nasal septum, and
themesopharyngealmucosa. In several cases, adenoidectomy
was combined by tympanocentesis and suction of the middle
ear fluid content. Middle ear fluids were visually analyzed
and categorized into serous or mucous groups. All surgeries
were performed by two ENT specialists having more than 10
years of experience (Z. Papp and T. Karosi). All parents gave
their informed consent before donating the tissue samples for
the study. The Institutional Ethical Committee approved our
study.The study was carried out according to the Declaration
of Helsinki.
2.2. Histopathologic Examination. According to previous
reports, combination of H.E. and Gram staining protocols
seems to be a usable method for the detection of biofilm exis-
tence and corresponding histopathologic changes, since H.E.
staining is for the investigation of microscopic architecture,
while Gram protocol stains various bacterial elements [25].
The first series of adenoid specimens (𝑛 = 59) were fixed in
10% (w/v) formaldehyde. Specimens were embedded in 15%
(w/v) purified gelatin (24 h, 56∘C) and refixed in 4% (w/v)
paraformaldehyde (24 h, 20∘C). Blocks were cryoprotected
in 20% (w/v) sucrose-solution (2 h, 4∘C) and sectioned into
5 𝜇m slides at −25∘C (MNT-200, Slee, Mainz, Germany).
Slides were stored in 0.1M PBS containing 0.03% (w/v)
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sodium-azide at 4∘C. Two consecutive 5 𝜇m frozen cut sec-
tions were examined using conventional staining with hema-
toxylin and eosin (H.E.) and conventional Gram staining,
respectively. The criteria for the histopathologic detection of
microbial biofilms were the presence of characteristic mor-
phology andGram positivity/negativity andmicrocolonies of
bacteria and the presence of the surrounding polysaccharide
layer upon examination by opticalmicroscopy [25]. Structure
and cellular infiltration of the epithelial and also the subep-
ithelial layers were correlated to the presence of bacterial
biofilms. Histologic pretreatment protocols were performed
by an independent laboratory assistant in all cases. Both sets
of histologic staining protocols were independently analyzed
by two researchers (P. Csomor and T. Karosi) blinded to
clinical diagnosis.
2.3. Nucleic Acid Extraction and Real-Time PCR Detection
of Respiratory Viruses. Second series of adenoid specimens
(𝑛 = 59) were processed for nucleic acid extraction
and purification, which was performed by High Pure Viral
Nucleic Acid Kit (Roche Applied Science, Basel, Switzerland)
according to the manufacturer’s instructions. Simultaneous
detection of respiratory viruses with potential pathogenic
role was performed by validated and commercial RT (reverse
transcriptase) and real-time PCR systems. The following
respiratory viruses were tested: influenza virus A and B (Iv-
A and B); respiratory syncytial virus A and B (RSV-A and
B), human metapneumovirus A and B (hMPV-A and B);
rhino- and enteroviruses (RV/EV); adenoviruses (AdV, 52
serotypes), and human bocavirus (hBoV 1, 2, 3, and 4).
All real-time PCR systems were purchased from Argene
(influenza A/B r-gene, Ref: 70-040; RSV/hMPV r-gene, Ref:
70-041; RV and EV/Cc r-gene, Ref: 70-042; AdV/hBoV r-
gene, Ref: 70-043). Amplification reactions were performed
following a uniform protocol according to themanufacturer’s
specifications and instructions and the results were validated
with positive, negative, and cellular controls provided within
the amplification kits. Real-time PCR products were elec-
trophoretized in 10% (w/v) agarose gel in all cases.
2.4. Statistical Analysis. Statistical assessments were per-
formed by Mann-Whitney’s 𝑈 probe with a 95% confidence
interval and by Chi-square test (SPSS 9.0 for Windows).
3. Results
3.1. Patient Groups. Altogether fifty-nine patients with ade-
noid hypertrophy who underwent adenoidectomy were
included in this study. The clinical history and findings of
physical and audiologic examinations were obtained during
the confirmation of the diagnosis of adenoid hypertrophy
and associated problems. Clinical pieces of information on
bronchial asthma, allergic rhinitis, and covering symptoms
were recorded in different patient groups before surgery
(Table 1).
3.2. Recurring Acute Otitis Media (RAOM) Group. For this
group of patients, the inclusion criteria were based on 2 or
more acute suppurative otitis media and acute sinusitis or
sinobronchitis episodes in the year before adenoidectomy
(Table 1). Patients suffering from otitis media with effusion
confirmed by physical examination and tympanometry were
excluded from this group. In contrast, associated obstructive
sleep apnea syndrome was not an exclusion criterion. This
group of patients consisted of sixteen males and nine females
(𝑛 = 25; mean age 5.12 years; range 3–11 years). The
average number of acute suppurative otitis media episodes
was 6.72/year (range: 2–14), while the acute sinusitis episodes
reached the average annual number of 5.41 (range: 2–
9) (Table 1). One patient had allergic rhinitis that was
based on the clinical history, on the physical examination,
and on the allergen-specific intracutaneous (Prick) skin
test. Preoperative systemic antibiotic treatment (amoxicillin,
cefuroxim, azithromycin, or clarithromycin) was performed
in all patients due to recurring acute upper airway tract
infections.
3.3. Otitis Media with Effusion (OME) Group. In this patient
group, the inclusion criteria were based on persisting middle
ear fluid content and Eustachian tube functional disor-
der confirmed by physical examination and tympanometry
(Table 1). Symptoms persisted more than six weeks in spite
of medical treatment including intranasal steroids and/or
systemic antihistamine therapy. Patients with unilateral or
bilateral middle ear effusion were also recruited in this group.
Obstructive sleep apnea syndrome was not an exclusion
criterion. This group of patients consisted of twelve males
and seven females (𝑛 = 19; mean age 4.63 years; range 3–8
years). The average number of acute suppurative otitis media
episodes was 1.21/year (range: 0–4), while the acute sinusitis
episodes reached the average annual number of 1.31 (range:
0–3) (Table 1). Nine patients had allergic rhinitis and four
patients were diagnosed with bronchial asthma. The diag-
nosis of bronchial asthma was based on the clinical history
and on the respiratory functional test. The final diagnosis of
bronchial asthma was stated by an experienced pulmonolo-
gist in all cases. Systemic antihistaminemedication (cetirizine
or desloratadine) and topical steroid (mometasone-furoate
monohydrate) treatment were performed in all patients.
3.4. Obstructive Sleep Apnea Syndrome (OSAS) Group. In this
group of patients, the inclusion criteria were based on the
persisting (more than three months) sleep apnea and snoring
confirmed by the heteroanamnesis obtained from the parents
(Table 1). Patients with several recurring acute suppurative
otitis media and acute sinusitis episodes or chronic otitis
media with effusion confirmed by physical examination and
tympanometry were excluded from this group. This group of
patients consisted of nine males and six females (𝑛 = 15;
mean age 4.93 years; range 3–11 years).The average number of
acute suppurative otitis media episodes was 0.33/year (range:
0-1), while the acute sinusitis episodes reached the average
annual number of 0.4 (range: 0-1) (Table 1). Four patients had
allergic rhinitis and two other patients had bronchial asthma.
3.5. Real-Time PCRDetection of Respiratory Viruses. Accord-
ing to the validated real-time PCR results, persisting A and
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1Acute suppurative otitis media. 2Acute sinusitis. 3Obstructive sleep apnea syndrome. 4Due to visual evaluation during intraoperative tympanocentesis and
suction. 5A: normal curve; B: flat curve due to middle ear fluid. C: deviated curve due to negative middle ear pressure. All tympanometric measurements were
performed the day before adenoidectomy. 6Recurring acute otitis media group. 7Otitis media with effusion group. 8Obstructive sleep apnea syndrome group.
B types of influenza virus (Iv-A and B) could not be detected
in the adenoid specimens (Tables 2 and 3). The detectability
of RSV and hMPV did not achieve a significant level and
could be established as an accidental association in different
patient groups (Tables 2–4). In contrast, RSV and hMPVwere
exclusively detected in theOMEgroup.Themainly associated
viral pathogens were originated from various serotypes of
RV/EV,AdV, andHBoV species (Tables 2–4). Table 2 presents
the individual coexpression patterns of different respiratory
viruses. All virus-negative cases (𝑛 = 7) belonged to the
RAOM group, while patients of OME and OSAS groups
were all characterized by various coexpressions of respiratory
viruses (Tables 3 and 4). The RAOM group was exclusively
associated with the presence of RV/EV AdV species (Tables 3
and 4). In the OSAS group, HBoV was detected in 54% of
cases, which was mainly coexpressed with RV/EV (20%) and
AdV serotypes (27%) (Table 4, Figure 1). Only one case was
characterized by individual persistence of HBoV (Table 4).
All specimens of the OME group were characterized by
HBoV (Tables 3 and 4, Figure 1). Furthermore, eight of nine
cases with individual expression of HBoV belonged to the
OME group (Table 4). It was found that individual presence
(𝑃 < 0.001, Chi-square test) or codetection (𝑃 < 0.05,
Chi-square test) of HBoV in the adenoid tissue is a strong
predictor of OME associated with adenoid hypertrophy
(Tables 3 and 4, Figure 1).
3.6. Histopathologic Examination. Histopathologic analysis
revealed inflammatory adenoid tissues with lymphocytic,
plasmacytic, or eosinophilic and polymorphonuclear infiltra-
tion of the subepithelial stroma in all cases. Bacterial biofilms
were detected in 21 (35.59%) of 59 patients with adenoid
hypertrophy (Table 3, Figure 2). In the biofilm-negative cases
(𝑛 = 38, 64.41%), histopathologic analysis revealed a regular
respiratory mucosa with predominantly lymphocytic infil-
tration of the subepithelial layer (Table 3, Figure 3). Overall,
the great majority (>95%) of biofilm-positive cases were
originated from the RAOM group, where the prevalence of
bacterial biofilms was 80% (Table 3). In contrast, biofilms
could not be detected in the OME group. In the OSAS group,
bacterial biofilms represented 6% of prevalence (Table 3).
Independently from the associated symptoms, all patients
diagnosed with allergic rhinitis were recruited into the
biofilm-negative group (Table 3). The presence of bacterial
biofilms was strongly associated to the histopathologic char-
acteristics of epipharyngeal mucosa and also to the dominant
inflammatory cell type of the subepithelial layer (Chi-square
test; Table 3, Figures 2 and 3). Biofilm-negative cases were
characterized by normal respiratory mucosa with columnar
ciliated epithelium and goblet cells (Table 3, Figure 2). Disin-
tegration or cellularmetaplasia of the respiratorymucosa was
strongly associated to the presence of biofilms (Chi-square-
test; Table 3, Figure 2). It was found that polymorphonuclear
or plasmacytic infiltrations and disintegrated architecture
of the subepithelial (stromal) layer are the most important
predictors of biofilm presence (Table 3, Figure 3). In con-
trast, predominant lymphocytic infiltration and the presence
of several centrum germinativum significantly decreased
the chance of biofilm detection (Chi-square-test; Table 3,
Figure 3).
4. Discussion
In the present study, we demonstrated the presence of bacte-
rial biofilms in 21 patients with adenoid hypertrophy by the
combined application of H.E. and Gram staining. Individual
presence or coinfections of respiratory viruses were detected
in 52 adenoid specimens. Results were correlated to the
integrity of respiratory mucosa and also to the microscopic
architecture of the subepithelial layer. It was found that
the presence of bacterial biofilms or persisting respiratory
viruses, mainly HBoV, is a strong predictor of RAOM and
OME, respectively. RAOM cases were significantly asso-
ciated with biofilm existence, epithelial destruction, and
stromal disintegration. Furthermore, all virus-negative cases
belonged to this group of patients. In contrast, OME cases
were characterized by biofilm negativity and normal archi-
tecture of the respiratory mucosa and the subepithelial layer.
Beyond that all OME cases were positive for HBoV; all indi-
vidual expressions of this virus were recruited in this patient
group. It should be established that the presence of HBoV
displayed a statistically significant correlation to OME cases
associated with adenoid hypertrophy. The main limitation
of our study is the relatively low number of subjects, which
should be increased in the future in order to obtain more
precise statistical correlations. Nevertheless, we could not
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Table 2: Individual pattern of respiratory virus specific real-time (RT) PCR.
Patient number Virus-specific real-time PCR
Infl A1 Infl B2 RSV3 hMPV4 RV/EV5 AV6 hBoV7 CC8
1 − − − − + + − +
2 − − − − + + + +
3 − − − − + − − +
4 − − − − + − − +
5 − − − − + + − +
6 − − − − − + + +
7 − − − − + − − +
8 − − − − − − − +
9 − − − − + + − +
10 − − − − + + − +
11 − − − − − + − +
12 − − − − − + − +
13 − − − − + − − +
14 − − − − + + − +
15 − − − − − − + +
16 − − − − − + + +
17 − − − − − + + +
18 − − − − − + − +
19 − − − − + + + +
20 − − − − + + − +
21 − − − − − − + +
22 − − − − + − + +
23 − − − − − − + +
24 − − − − + + − +
25 − − − − + − + +
26 − − − + − − + +
27 − − − − + − − +
28 − − − − − − − +
29 − − − − + − + +
30 − − − − + + + +
31 − − − − − − + +
32 − − − − − − + +
33 − − − − − + − +
34 − − − − − + − +
35 − − − − + + − +
36 − − − − − − + +
37 − − − − − + − +
38 − − − − − + + +
39 − − − − − + − +
40 − − − − − − − +
41 − − − − − + − +
42 − − − − − + + +
43 − − − − − − − +
44 − − − − − − + +
45 − − − − − + − +
46 − − − − − − + +
47 − − + − + − + +
48 − − − − − − − +
49 − − − − − − − +
50 − − − − + + + +
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Table 2: Continued.
Patient number Virus-specific real-time PCR
Infl A1 Infl B2 RSV3 hMPV4 RV/EV5 AV6 hBoV7 CC8
51 − − − − − − − +
52 − − − − − − + +
53 − − − − − + − +
54 − − − − + + + +
55 − − − − + + − +
56 − − − − − − + +
57 − − − + − − + +
58 − − − − − − + +
59 − − − − + + + +
1Influenza-A virus, 2influenza-B virus, 3respiratory syncytial virus, 4human metapneumovirus, 5rhinovirus and enterovirus, 6adenovirus, 7human bocavirus,
and 8cellular control.















































































RAOM (n = 25)
OSAS (n = 15)
P < 0.001
OME (n = 19)
P < 0.05
Figure 1: Graphic representation of respiratory virus specific real-time PCR results in different patient groups. RAOM: recurring acute otitis
media; OME: otitis media with effusion; OSAS: obstructive sleep apnea syndrome.
exclude the seasonal pattern of respiratory virus infections
in our patients. Furthermore, biofilm detection was based
on the combined applications of H.E. and Gram staining
protocols that were not correlated to the widely accepted
methods of biofilmdetection such as FISH (fluorescent in situ
hybridization), CLSM (confocal laser scanning microscopy),
and SEM (scanning electron microscopy) [25]. We did not
intend to make a precise identification of bacterial species,
because the presence of biofilm itself is thought to be themost
important factor in the pathogenesis of OME and RAOM
cases [3, 9–11].
Themechanical hypothesis emphasizes the importance of
nasopharyngeal obstruction caused by adenoid hypertrophy
[1, 7]. This theory can explain only a limited fraction of
symptoms associatedwith adenoid hypertrophy, such as nasal
obstruction, hyponasality, olfactory dysfunction, snoring,
mouth breathing, and disturbed facial and teeth development
[1, 5, 12, 13]. It has been reported that physical disproportion
between the volume of adenoid and epipharyngeal space is
the most important factor in the pathogenesis of OSAS [4,
5, 12]. Beyond the serious pathophysiological consequences,
OSAS may cause various behavioral problems, such as anxi-
ety, depression and attention deficits, or hyperactivity [4, 5].
The reservoir hypothesis emphasizes the direct or indirect
role of persisting respiratory pathogens in the pathogenesis
of RAOM and OME associated with adenoid hypertrophy
[9, 15, 17, 21]. The main bacterial pathogens in RAOM cases
are the Streptococcus pneumoniae,Moraxella catarrhalis, and
Haemophilus influenzae [22–24, 26]. Both streptococci and
Haemophilus species are potent biofilm-forming pathogens
that may result in chronic persistence in the adenoid lacunae
[21, 23, 26]. Acute exacerbations of otitis media may originate
from this bacterial reservoir due to ascending reinfections via
the Eustachian tube [1, 9, 17]. These bacteria can usually be
cultured from the purulent effusion obtained from themiddle
ear [24, 26].

















Figure 2: Histopathologic representation of the respiratory epithelium in adenoid specimens of patients from OME and RAOM groups.
(A1) At low magnification, regular columnar epithelium can be detected (black arrow, H.E.). (A2) Higher magnification view of the previous
section. Black arrow indicates intact ciliated cells. (A3) Biofilm structures cannot be detected on the surface of epipharyngeal epithelium
(Gram). (A4) Higher magnification view of the previous section. (B1)The epithelial layer is disintegrated and covered by a thick eosinophilic
structure (black arrow, H.E.). (B2) At higher magnification, biofilm layer is a well identifiable structure (black arrow). (B3) Gram staining
reveals a bacterial biofilm consisted of individual colonies of Gram-positive cocci (black arrow). (B4) Higher magnification view of the
previous section. White arrow indicates Gram-positive cocci in a chain-pattern of streptococci.


















Figure 3: Histopathologic representation of the stromal substance in adenoid specimens of patients from the OME and RAOM groups.
(A1) Normal centrum germinativum (white arrow, H.E.). (A2) Higher magnification of the previous section. White arrow indicates large
lymphocytes, while immunoblasts and centroblasts are shown by black arrow. (A3) Agarose gel electrophoresis of real-time PCR products
of the identical specimen. Positive reactions were shown for Adenovirus (AdV), Human Bocavirus (hBoV), and for Rhinovirus-Enterovirus
(RV/EV) serotypes. CC: cellular control. (B1) Disintegrated stromal substance without centrum germinativums (white arrow, H.E.). (B2) At
higher magnification view, several polymorphonuclear cells (black arrow) and plasmocytes (white arrow) can be identified. (B3) Agarose
gel electrophoresis of real-time PCR products of the identical specimen. The sample showed individual expression of Adenovirus (AV). CC:
cellular control.
In contrast, OME is a chronic disease that is characterized
by conductive hearing loss, persisting type-B tympanograms,
special otoscopic findings, painless aural fullness, and by
mental problems in some cases [3, 6, 10, 11]. The serous or
mucous effusions obtained during tympanocentesis or venti-
lation tube insertion are often negative for bacteria according
to the results of conventional microbiological analysis [3,
9, 15, 16]. At this time, OME is suspected to be a complex
immunologic disorder of the middle ear cleft, which is
mediated by the interactions of persisting respiratory viruses
and impaired immune responses [15, 16]. It has been reported
that RV/EV species, HBoV, RSV, and AdV might play an
important role in the pathogenesis of OME [18, 27–30].
Suggesting the importance of B-cell mediated immunoreac-
tion, Rezes et al. have reported increased albumin-globulin
ratio (>0.7) in the middle ear fluids obtained from patients
with OME [20]. Recent studies have demonstrated increased
expression of IL-4, IL-11, and IFN-gamma and decreased
levels of IL-1, TNF-alpha, or TGF-beta in the serous or
mucous middle ear effusions suggesting the role of humoral
immune response in the pathogenesis of OME [14–16, 20].
According to our results, distinct clinical pictures of
adenoid hypertrophy can be characterized by different
histopathologic and virus expression profiles. Adenoidec-
tomy with or without tympanocentesis or ventilation tube
insertion still remains the gold standard for the treatment of
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Table 3: Summary of respiratory virus specific real-time (RT) PCR
results and histologic findings in different patient groups.








Infl A 0 0 0
Infl B 0 0 0
RSV 0 1 0
hMPV 0 2 0
RV/EV 8 7 11
AV 10 7 8
hBoV 0 19 8
Cellular control 25 19 15
Biofilm positivity 20 0 1
Mucosa
Normal respiratory



























Undetectable 7 (28%) 0 0
RV/EV 3 (12%) 0 3 (20%)
RV/EV + AV 5 (20%) 0 4 (27%)
RV/EV + hBoV 0 1 (5%) 3 (20%)
RV/EV + AV +
hBoV 0 5 (26%) 1 (7%)
RV/EV + RSV +
hBoV 0 1 (5%) 0
AV 10 (40%) 0 0
hBoV 0 8 (42%) 1 (7%)
AV + hBoV 0 2 (10%) 3 (20%)
hMPV + hBoV 0 2 (10%) 0
adenoid hypertrophy; however, further research may intro-
duce targeted therapies in the future. In conclusion, adenoid
hypertrophy-associated conditions are diseases of multifac-
torial agents involving disturbed local immune response and
chronic inflammation. Furthermore, persisting respiratory
viruses and bacterial biofilmsmight contribute to the damage
of respiratory epithelium and subsequent hyperplasia of
the subepithelial layer leading to functional disorder of
the Eustachian tube and impaired immunoreactivity of the
middle ear cleft.
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